Johnson Financial Group Inc. Boosts Stock Position in Phreesia, Inc. (NYSE:PHR)

Johnson Financial Group Inc. increased its stake in shares of Phreesia, Inc. (NYSE:PHR) by 381.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,131 shares of the company’s stock after purchasing an additional 896 shares during the period. Johnson Financial Group Inc.’s holdings in Phreesia were worth $28,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also made changes to their positions in PHR. R Squared Ltd acquired a new stake in shares of Phreesia in the fourth quarter valued at about $30,000. BankPlus Trust Department acquired a new position in Phreesia in the fourth quarter valued at about $34,000. Venturi Wealth Management LLC acquired a new position in shares of Phreesia in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC lifted its stake in Phreesia by 154.6% during the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company’s stock worth $89,000 after purchasing an additional 2,090 shares in the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company’s stock valued at $107,000 after acquiring an additional 459 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on PHR. Piper Sandler reaffirmed an “overweight” rating and set a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group increased their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, March 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. Citigroup increased their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Finally, DA Davidson dropped their price target on shares of Phreesia from $36.00 to $34.00 and set a “buy” rating on the stock in a research note on Monday, April 14th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has a consensus rating of “Buy” and a consensus target price of $31.33.

Insider Buying and Selling

In other Phreesia news, CFO Balaji Gandhi sold 28,759 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the completion of the transaction, the chief financial officer now directly owns 116,174 shares in the company, valued at approximately $3,485,220. The trade was a 19.84 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total value of $103,901.12. Following the completion of the sale, the general counsel now owns 142,630 shares of the company’s stock, valued at $4,238,963.60. This trade represents a 2.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 112,660 shares of company stock worth $3,124,263 in the last ninety days. Insiders own 5.80% of the company’s stock.

Phreesia Stock Performance

Shares of PHR opened at $24.87 on Wednesday. The company has a 50-day moving average of $25.34 and a two-hundred day moving average of $24.45. The stock has a market cap of $1.46 billion, a P/E ratio of -16.92 and a beta of 0.82. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.